Coronavirus disease patients’ views and experiences of pharmaceutical care services in Lebanon
Tareq L. Mukattash, Anan S. Jarab, Walid Al‐Qerem, Rana Abu Farha, Rania Itani, Samar Karout, Ibrahim Lewis Mukattash
Abstract
OBJECTIVES: This study aimed to explore the experiences and views of domiciliary coronavirus disease (COVID-19) patients towards pharmaceutical care services provided during their infection. METHODS: This was a single-centred observational study conducted among home-treated COVID-19 patients (n = 500), who were tested positive for COVID-19 in a medical centre in Lebanon. KEY FINDINGS: Out of the 500 home-treated COVID-19 patients invited to participate in the study, 279 patients completed the questionnaire. Although the participants had a good view of pharmacists caring for COVID-19 patients (mean view score: 17.79/25), their treatment experiences were unsatisfactory (mean experience score: 1.51/4). CONCLUSIONS: COVID-19 patients reported minimal involvement of pharmacists in their treatment. Therefore, in response to the COVID-19 pandemic, healthcare authorities should intervene in restructuring, guiding and reviewing unrealized new pharmaceutical services to COVID-19 outpatients.